Feb, 2008
Jan, 2008
News / Therapeutic Area News
FDA Approves Additional Indication for Astellas' MYCAMINE®
Astellas Pharma Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved their Supplemental New Drug Application (sNDA) seeking approval for the use of MYCAMINE®...
Read MoreNews / Therapeutic Area News
Cardiome and Astellas Announce Regulatory Update
Vancouver, Canada and Deerfield, Illinois, USA, January 21, 2008 -- Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) and its co-development partner Astellas Pharma US, Inc. (“Astellas”) today...
Read More